Key Factors QSPM

Strengths
Very Solid Brand Equity
Great Advertising
Economies of scale
Track record of the organization
Market share leader
Weakness
Declining Net Profit
Lack of diversity in merchandise
Weakness in certain merchandise departments such as ladies sportswear, mattresses, handbags
Current customer perception slightly negative about the brand
Total
Opportunities
Leverage buyout to consolidate the segment and boost presence
Rejig the merchandise portfolio towards those items which are growing faster
Enhancement in technology and automation for retail industry
Threats
Change in laws effecting wage increase
Competitors getting desperate
Price reduction by competitors
Change in customer demand and preference
Total
 Omni-channel sales and Manage inventories and
Weight
International Expansion reduce cost

AS TAS AS TAS

0.1 4 0.4 3 0.3

0.05 0 0 0 0
0.07 3 0.21 4 0.28
0.3 0 0 0 0
0.1 3 0.3 3 0.3
0 0
0.1 3 0.3 3 0.3
0.09 3 0.27 2 0.18
0.07 4 0.28 3 0.21
0.12 0 0 0 0
1
0 0
0.04 4 0.16 3 0.12
0.06 4 0.24 3 0.18
0.03 3 0.09 3 0.09
0 0
0.08 3 0.24 4 0.32
0.09 2 0.18 3 0.27
0.1 3 0.3 3 0.3
0.6 0 0 0 0
1 2.97 2.85
 Key Factors QSPM

Strengths
Largest pharmaceutical company in the world and spread over more than 50 countries
Excellent R&D creating innovative and breakthrough products
Has over 100,000 employees as a part of the organization
Mergers and acquisitions with big pharmaceutical companies increasing brand reputation
Weaknesses
Very limited penetration of biologics market
Overreliance on the mature market (U.S.) and a small number of distributors
Tough competition from other major pharmaceutical brands means limited scope for market share growth
Negative brand image due to involvement in largest healthcare fraud of marketing its drug illegally
Total
Opportunities
Strategic agreements with other pharmaceutical companies and orgs to boost its research.
Increasing awareness about healthcare needs
Global penetration through mergers and acquisitions
Increasing demand for quality healthcare solutions
E-Commerce
Threats
Risk of unsuccessful new products
Regulatory environment is becoming more & more stringent
Economic slowdown in European markets
Increased market competitions
Losing of patent individuality by focusing on one product
Total
 Increase R&D funds to
Market Development
increase probability of
Weight specifically on Emerging
developing new
Markets(China,India)
products
AS TAS AS TAS

0.09 4 0.36 3 0.27

0.08 3 0.24 2 0.16
0.4 0 0 0 0
0.03 0 0 0 0

0.06 3 0.18 3 0.18

0.1 3 0.3 2 0.2
0.04 0 0 0
0.2 2 0.4 3 0.6
1

0.1 0 0 0 0
0.05 3 0.15 3 0.15
0.3 3 0.9 3 0.9
0.04 0 0 0 0
0.08 0 0 0 0

0.2 3 0.6 3 0.6

0.04 3 0.12 3 0.12
0.08 3 0.24 2 0.16
0.02 0 0 0 0
0.09 2 0.18 3 0.27
1 3.67 3.61
 Your Firm'sDivision Top Firm in Industry Relative Market Industry Sales
Division Revenues Division Revenues Share Position Growth Rate

U.S 29746000000 22425000000 0.2 5

International 51542000000 26279000000 0.6 -10

20

10

Industry Sales
Growth Rate
0
1 0.8 0.6 0.4

-10

-20

Relative Market
Share Position
 20

10

0
0.6 0.4 0.2 0

-10

-20

ative Market
are Position
Relative Industry
Market Sales
Share Growth 20
Position Rate
15
0.2 5
0.2 -10 10

0.8 10 5

Axis Title
0
1 0.9 0.8 0.7 0.6 0.5 0.4
-5

-10

-15

-20
Axis Title
 20

15

10

0
0.7 0.6 0.5 0.4 0.3 0.2 0.1
-5

-10

-15

-20
Axis Title